(Q37790475)

23 August 2017

title

Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer (English)

1 reference

prenatal exposure delayed effects

23 August 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854896

16 July 2024

author name string

Rodney R. Dietert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854896

16 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20854896

16 July 2024

publication date

18 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0890623810003035?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

https://api.elsevier.com/content/article/PII:S0890623810003035?httpAccept=text/plain

16 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

16 July 2024

published in

Reproductive Toxicology

1 reference

23 August 2017

volume

31

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

319-326

1 reference

Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk

23 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.

16 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Critical windows in development of the rodent immune system

16 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immunotoxicity: the risk is real

16 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Perinatal immunotoxicity: why adult exposure assessment fails to predict risk

16 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability

16 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives

16 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Identifying patterns of immune-related disease: use in disease prevention and management

16 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The burden of illness experienced by young children associated with asthma: a population-based cohort study

16 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The burden of asthma in children: a European perspective

16 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The environment and asthma in US inner cities

16 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Asthma disparities in urban environments

16 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Quality of care for childhood asthma: estimating impact and implications

16 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The accelerating epidemic of childhood diabetes

16 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

16 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review.

16 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Cancer and inflammation: implications for pharmacology and therapeutics

16 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immunity, Inflammation, and Cancer

16 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement.

16 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Children's health risk assessment: incorporating a lifestage approach into the risk assessment process

16 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment

16 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The interplay between the immune and central nervous systems in neuronal injury.

16 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Neuroimmunomodulation in the pathogenesis of Alzheimer's disease

16 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy

16 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Neuroinflammation in Parkinson's disease

16 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma

16 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

A new look at the pathogenesis of asthma

16 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood

16 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Autoimmune thyroid disease: unlocking a complex puzzle

16 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Inflammatory bowel disease

16 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

16 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Dendritic cells in intestinal homeostasis and disease.

16 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.

16 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Uncontrolled immune response in acute myocardial infarction: unraveling the thread.

16 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The role of innate immune pathways in type 1 diabetes pathogenesis

16 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The geoepidemiology of type 1 diabetes

16 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immunologic screening of children with recurrent otitis media

16 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Children with recurrent otitis show defective IFNγ-producing cells in adenoids

16 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immune-mediated audiovestibular disorders in the paediatric population: a review

16 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

The role of complement Factor H in age-related macular degeneration: a review.

16 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immune regulation in the retina

16 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immunosenescence and juvenile idiopathic arthritis

16 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Environmental factors and the geoepidemiology of juvenile idiopathic arthritis

16 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Skin immune sentinels in health and disease

16 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Skin-resident T cells: the ups and downs of on site immunity

16 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Alopecia areata: a tissue specific autoimmune disease of the hair follicle

16 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

16 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Bone involvement in clusters of autoimmune diseases: Just a complication?

16 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Infection, immune responses and the aetiology of childhood leukaemia

16 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia

16 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immune privilege and inflammation of the testis

16 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

A block in the road to fertility: autoantibodies to heat-shock protein 90-beta in human ovarian autoimmunity

16 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Role of TGF-betas in normal human endometrium and endometriosis

16 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T cells

16 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

Autoimmune kidney diseases

16 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.REPROTOX.2010.09.006

16 July 2024

Identifiers

1 reference

23 August 2017

1 reference